← All trials
NCT04731467
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 19, 2021
- Primary completion
- Feb 29, 2024
- Completion date
- Mar 31, 2024
- First posted
- Feb 1, 2021
- Last posted
- Oct 22, 2021
- Enrollment
- 74
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Purple BiotechLead sponsor
- Purple BiotechStudy director
- Bristol-Myers SquibbCollaborator
- Purple BiotechOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.